This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.20% per year. These returns cover a period from January 1, 1988 through April 1, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Zacks News
Hello Group Inc. Sponsored ADR (MOMO) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Hello Group Inc. Sponsored ADR (MOMO) delivered earnings and revenue surprises of 38.46% and 0.71%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
CrowdStrike Holdings (CRWD) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
CrowdStrike (CRWD) delivered earnings and revenue surprises of 9.30% and 2.03%, respectively, for the quarter ended January 2023. Do the numbers hold clues to what lies ahead for the stock?
Is Cognyte Software (CGNT) Outperforming Other Computer and Technology Stocks This Year?
by Zacks Equity Research
Here is how Cognyte Software Ltd. (CGNT) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.
Cognyte Software Ltd. (CGNT) Reports Q3 Loss, Lags Revenue Estimates
by Zacks Equity Research
Cognyte Software Ltd. (CGNT) delivered earnings and revenue surprises of -31.58% and 9.52%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Domo (DOMO) Reports Q3 Loss, Tops Revenue Estimates
by Zacks Equity Research
Domo (DOMO) delivered earnings and revenue surprises of 50% and 3.40%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
PagerDuty (PD) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
PagerDuty (PD) delivered earnings and revenue surprises of 200% and 1.55%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Hewlett Packard Enterprise (HPE) Meets Q4 Earnings Estimates
by Zacks Equity Research
HP Enterprise (HPE) delivered earnings and revenue surprises of 0% and 6.12%, respectively, for the quarter ended October 2022. Do the numbers hold clues to what lies ahead for the stock?
Cognyte Software Ltd. (CGNT) Reports Q2 Loss, Lags Revenue Estimates
by Zacks Equity Research
Cognyte Software Ltd. (CGNT) delivered earnings and revenue surprises of 63.64% and 17.84%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
EGain (EGAN) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
eGain (EGAN) delivered earnings and revenue surprises of 200% and 0.38%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Asana, Inc. (ASAN) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Asana, Inc. (ASAN) delivered earnings and revenue surprises of 12.82% and 5.75%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Smartsheet (SMAR) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Smartsheet (SMAR) delivered earnings and revenue surprises of 50% and 3.49%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Sumo Logic, Inc. (SUMO) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Sumo Logic, Inc. (SUMO) delivered earnings and revenue surprises of 28.57% and 3.63%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
Box (BOX) Q2 Earnings Meet Estimates
by Zacks Equity Research
Box (BOX) delivered earnings and revenue surprises of 0% and 0.47%, respectively, for the quarter ended July 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for August 17th
by Zacks Equity Research
CGNT, AUD, and CBAN have been added to the Zacks Rank #5 (Strong Sell) List on August 17, 2022.
Cognyte Software Ltd. (CGNT) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Cognyte Software Ltd. (CGNT) delivered earnings and revenue surprises of -758.33% and 22.83%, respectively, for the quarter ended April 2022. Do the numbers hold clues to what lies ahead for the stock?
New Strong Sell Stocks for April 18th
by Zacks Equity Research
AGNC, BEP, and CGNT have been added to the Zacks Rank #5 (Strong Sell) List on April 18, 2022.
Cognyte Software Ltd. (CGNT) Q4 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Cognyte Software Ltd. (CGNT) delivered earnings and revenue surprises of -27.27% and 3.20%, respectively, for the quarter ended January 2022. Do the numbers hold clues to what lies ahead for the stock?
Oblong, Inc. (OBLG) Reports Q4 Loss, Tops Revenue Estimates
by Zacks Equity Research
Oblong, Inc. (OBLG) delivered earnings and revenue surprises of 10% and 14.71%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Cognyte Software Ltd. (CGNT) Upgraded to Buy: What Does It Mean for the Stock?
by Zacks Equity Research
Cognyte Software Ltd. (CGNT) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Jabil (JBL) Q3 Earnings Beat Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Jabil's (JBL) third-quarter fiscal 2021 results reflect benefits from contract wins in healthcare, mobility, cloud-connected devices and semi-cap despite supply chain headwinds.
Zacks.com featured highlights include: Ecopetrol, TheStreet, Cogentix, Fortuna Silver and CPI Aerostructures
by Zacks Equity Research
Zacks.com featured highlights include: Ecopetrol, TheStreet, Cogentix, Fortuna Silver and CPI Aerostructures
5 Bargain Breakout Stocks Offering Amazing Returns
by Swarup Gupta
This involves zeroing in on stocks trading within a tight range and buying them when they step out of this band.
Laborie Medical Technologies to Acquire Cogentix Medical
by Zacks Equity Research
Laborie Medical Technologies will buy all of the outstanding shares of Cogentix Medical (CGNT) for a net worth of $239 million.
Cogentix Medical (CGNT) Looks Good: Stock Adds 13.3% in Session
by Zacks Equity Research
The shares of Cogentix Medical (CGNT) rose over 13% yesterday after reports surfaced that the company is going to be acquired by Laborie Medical Technologies.
Cogentix (CGNT) Stock Near 52-Week High: More Room to Run?
by Zacks Equity Research
Cogentix Medical (CGNT) stock continues to hover around the 52-week high mark reached on Dec 27, courtesy of its new strategies.